With a robust track record in early-stage investments, the fund manager has completed over 50 deals primarily in technology and healthcare sectors across North America and Europe. Leveraging a data-driven approach, they emphasize operator-first strategies to support portfolio companies in scaling effectively. Notable exits include several high-growth firms, reflecting a keen ability to identify and nurture promising opportunities. Their strategic focus on thematic investments has consistently delivered strong returns, positioning them as a significant player in the venture capital landscape.